Regulation of the cAMP cascade, gene expression and immune function by cannabinoid receptors

Journal of Neuroimmunology

Volumn 83, Issue 1-2, 1998, Pages 124-132

  Kaminski, Norbert E ^a  

^a B 330 Life Sci Bldg Michigan S ^*  (United States)

Author keywords

Cannabinoid receptors; Gene expression; Immune modulation

Indexed keywords

ADENYLATE CYCLASE; CANNABINOID; CANNABINOID RECEPTOR; CYCLIC AMP; CYCLIC AMP DEPENDENT PROTEIN KINASE; DRONABINOL; NITRIC OXIDE SYNTHASE; TRANSCRIPTION FACTOR;

ANIMAL CELL; ARTICLE; CELLULAR IMMUNITY; GENE EXPRESSION; HELPER CELL; HUMAN; HUMAN CELL; MACROPHAGE; NONHUMAN; PRIORITY JOURNAL; RECEPTOR BINDING; SIGNAL TRANSDUCTION;

ANIMALS; CANNABINOIDS; CYCLIC AMP; GENE EXPRESSION REGULATION; HUMANS; RECEPTORS, CANNABINOID; RECEPTORS, DRUG; SIGNAL TRANSDUCTION;

EID: 0032520649     PISSN: 01655728     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0165-5728(97)00228-2     Document Type: Article

References (61)

1. Alonso A., Carvalho J., Alonso-Torre S., Nunez L., Bosca L., Crespo M. Nitric oxide synthesis in rat peritoneal macrophages is induced by IgE/DNP complexes and cyclic AMP analogues: evidence in favor of a common signaling mechanism. J. Immunol. 154:1995;6475-6483.
2. Bayewitch M., Avidor-Reiss T., Levy R., Barg J., Mechoulam R. The peripheral cannabinoid receptor: adenylate cyclase inhibition and G-protein coupling. FEBS Lett. 375:1995;143-147.
3. Bouaboula M., Rinaldi M., Carayon P., Carillon C., Delpech B., Shire D., Le Fur G., Casellas P. Cannabinoid-receptor expression in human leukocytes. Eur. J. Biochem. 214:1993;173-180.
4. Burgering B.M.T., Pronk G.J., van Weeren P.C., Chardin P., Bos J.L. cAMP antagonizes p21ras-directed activation of extracellular signal-regulated kinase 2 and phosphorylation of mSos nucleotide exchange factor. EMBO J. 12:1993;4211-4220.
5. Chen D., Rothenberg E. Molecular basis for developmental changes in interleukin-2 gene inducibility. Mol. Cell. Biol. 13:1993;228-237.
6. Condie R., Herring A., Koh W.S., Lee M., Kaminski N.E. Cannabinoid inhibition of adenylate cyclase-mediated signal transduction and IL-2 expression in the murine T-cell line, EL4.IL-2. J. Biol. Chem. 271:1996;13175-13183.
7. Cook S.J., McCormick F. Inhibition by cAMP of the Ras-dependent activation of Raf. Science. 262:1993;1069-1072.
8. Facci L., Dal Toso R., Romanello S., Buriani A., Skaper D., Leon A. Mast cells express a peripheral cannabinoid receptor with differential sensitivity to anandamide and palmitoylethanolamide. Proc. Natl. Acad. Sci. USA. 92:1995;3376-3380.
9. Gerard C.M., Mollereau C., Vassart G., Parmentier M. Nucleotide sequence of a human cannabinoid receptor cDNA. Nucl. Acids Res. 18:1990;7142.
10. Gerard C.M., Mollereau C., Vassart G., Parmentier M. Molecular cloning of a human cannabinoid receptor which is also expressed in testis. Biochem. J. 279:1991;129-134.
11. Gonzalez G.A., Montminy M.R. Cyclic AMP stimulates somatostatin gene transcription by phosphorylation of CREB at serine 133. Cell. 59:1989;675-680.
12. Graves L.E., Bornfeldt R.E., Raines E.W., Potts B.C., MacDonald S.G., Ross R., Krebs E.G. Protein kinase A antagonizes platelet-derived growth factor-induced signaling by mitogen-activated protein kinase in human arterial smooth muscle cells. Proc. Natl. Acad. Sci. USA. 90:1993;10300-10304.
13. Grieco D., Porcellini A., Avvedimento E.V., Gottesman M.E. Requirement for cAMP-PKA pathway activation by M phase-promoting factor in the transition from mitosis to interphase. Science. 271:1996;1718-1723.
14. Grilli, M., Chiu, J.-S., Lenardo, M., 1993. NF-κB and Rel, participants in a multiform transcriptional regulatory system. International Review of Cytology: A Survey of Cell Biology. Academic Press, San Diego, CA, pp. 1-62.
15. Hadden J.W., Hadden E.M., Haddox M.K., Goldberg N.D. Guanosine 3′:5′-cyclic monophosphates: a possible intracellular mediator of mitogenic influences in lymphocytes. Proc. Natl. Acad. Sci. USA. 69:1972;3024-3027.
16. Hafner S., Adler H.S., Mischak H., Janosch P., Heidecker G., Wolfman A., Pippig S., Lohae M., Ueffing M., Kolch W. Mechanism of inhibition of Raf-1 by protein kinase A. Mol. Cell. Biol. 14:1994;6696-6703.
17. Hagiwara M., Alberts A., Brindle P., Meinkoth J., Feramisco J., Deng T., Karin M., Shenolikar S., Montminy M. Transcriptional attenuation following cAMP induction requires PP-1-mediated dephosphorylation of CREB. Cell. 70:1992;105-113.
18. Hai T.-Y., Curran T. Cross-family dimerization of transcription factors Fos: Jun and ATF/CREB alters DNA binding specificity. Proc. Natl. Acad. Sci. USA. 88:1991;3720-3724.
19. Harris L.S., Carchman R.A., Martin B.R. Evidence for the existence of specific cannabinoid binding sites. Life Sci. 22:1978;1131-1138.
20. Hibbs J.B., Taintor R.R., Vavrin Z. Macrophage cytotoxicity: role for L-arginine deiminase and imino nitrogen oxidation to nitrite. Science. 235:1987;473-476.
21. Hordijk P.L., Verlaan I., Janink K., van Corven E.J., Moolenaar W.H. cAMP abrogates the p21ras-mitogen-activated protein kinase pathway in fibroblasts. J. Biol. Chem. 269:1994;3534-3538.
22. Howlett A.C. Cannabinoid inhibition of adenylate cyclase: biochemistry of the response in neuroblastoma cell membranes. Mol. Pharmacol. 27:1985;429-436.
23. Howlett A.C., Fleming R.M. Cannabinoid inhibition of adenylate cyclase: pharmacology of the response in neuroblastoma cell membranes. Mol. Pharmacol. 26:1984;532-538.
24. Howlett A.C., Qualy J.M., Khachtrian L.L. Involvement of Gi in the inhibition of adenylate cyclase by cannabimimetic drugs. Mol. Pharmacol. 29:1986;307-313.
25. Hsueh Y.P., Lai M.Z. c-Jun N-terminal kinase but not mitogen-activated protein kinase is sensitive to cAMP inhibition in T-lymphocytes. J. Biol. Chem. 270:1995;18094-18098.
26. Ivashkiv L.B., Liou H.C., Kara C.J., Lamph W.W., Verma I.M., Glimcher L.H. mXBP/CRE-BP2 and c-Jun form a complex which binds cAMP, but not to the 12-O-tetradecanoyl phorbol-13-acetate response element. Mol. Cell. Biol. 10:1990;1609-1621.
27. 9-tetrahydrocannabinol is mediated through the inhibition of NF-κB/Rel activation. Mol. Pharmacol. 50:1996;334-341.
28. 1. Proc. Natl. Acad. Sci. USA. 83:1988;6072-6076.
29. Kaminski N.E., Abood M.E., Kessler F.K., Martin B.R., Schatz A.R. Identification of a functionally relevant cannabinoid receptor on mouse spleen cells that is involved in cannabinoid-mediated immune modulation. Mol. Pharmacol. 42:1992;736-742.
30. Kaminski N.E., Koh W.S., Lee M., Yang K.H., Kessler F.K. Suppression of the humoral immune response by cannabinoids is partially mediated through inhibition of adenylate cyclase by a pertussis toxin-sensitive G-protein coupled mechanism. Biochem. Pharmacol. 48:1994;1899-1908.
31. Kammer G.M. The adenylate cyclase-cAMP-protein kinase A pathway and regulation of the immune response. Immunol. Today. 9:1988;222-229.
32. Koh W.S., Yang K.H., Kaminski N.E. Cyclic AMP is an essential factor in immune responses. Biochem. Biophys. Res. Commun. 206:1995;703-709.
33. Koh W.S., Lee M., Yang K.H., Kaminski N.E. Expression of functional glucagon receptors on mouse splenocytes. Life Sci. 58:1996;741-751.
34. Koh W.S., Jeon Y.J., Herring A., Kaminski N.E. Transient CRE- and κB site binding is cross regulated by a cAMP-dependent protein kinase and protein phosphatase in mouse splenocytes. Life Sci. 60:1997;425-432.
35. Koide M., Kawahara Y., Nakayama I., Tsuda T., Yokoyama M. Cyclic AMP-elevating agents induce an inducible type of nitric oxide synthase in cultured vascular smooth muscle cells. J. Biol. Chem. 268:1993;24959-24966.
36. Lee H.J., Masuda E.S., Arai N., Arai K., Yokota T. Definition of cis-regulatory elements of the mouse interleukin-5 gene promoter. J. Biol. Chem. 270:1995;17541-17550.
37. Lowenstein C.J., Alley E.W., Raval P., Snowman A.M., Snyder S.H., Russell S.W., Murphy W.J. Macrophage nitric oxide synthase gene: two upstream regions mediate induction by interferon g and lipopolysaccharide. Proc. Natl. Acad. Sci. USA. 90:1993;9730-9734.
38. Maraguchi A., Miyazaki K., Fauci A.S. Inhibition of human B-cell activation by diterpine forskolin: interference with B-cell growth factor-induced G1 to S transition of the B-cell cycle. J. Immunol. 133:1984;1283-1287.
39. Matsuda L.A., Lolait S.J., Brownstein M.J., Young A.C., Bonner T.I. Structure of a cannabinoid receptor and functional expression of the cloned cDNA. Nature (London). 346:1990;561-564.
40. Munro S., Thomas K.L., Abu-Shaar M. Molecular characterization of a peripheral receptor for cannabinoids. Nature (London). 365:1993;61-65.
41. Muroi M., Suzuki T. Role of protein kinase A in LPS-induced activation of NK-κB proteins of a mouse macrophage-like cell-line, J774. Cell. Signal. 5:1993;289-298.
42. Nakano Y., Pross S., Friedman H. Contrasting effect of delta-9-tetrahydrocannabinol on IL-2 activity in spleen and lymph node cells of mice of different ages. Life Sci. 52:1993;41-51.
43. Novak T.J., Chen D., Rothenberg E.V. Interleukin-1 synergy with phosphoinositide pathway agonists for induction of interleukin-2 gene expression: molecular basis of costimulation. Mol. Cell. Biol. 10:1990;6325-6334.
44. Novotney M., Chang Z.-L., Uchiyama H., Suzuki T. Protein kinase C in tumoricidal activation of mouse macrophage cell lines. Biochemistry. 30:1991;5597-5604.
45. Palmer R.M.J., Ashton D.S., Moncada S. Vascular endothelial cells synthesize nitric oxide from L-arginine. Nature (London). 333:1988;664-666.
46. Pepe S., Ruggiero A., Tortora G., Ciaardiello F., Garbi C., Yokozaki H., Cho-Chung Y.S., Clair T., Skalhegg B.S., Bianco A.R. Flow cytometric detection of the RI alpha subunit of type-I cAMP-dependent protein kinase in human cells. Cytometry. 15:1994;73-79.
47. Russell D.H. Type I cyclic AMP-dependent protein kinase as a positive effector of growth. Adv. Cyclic Nucleotide Res. 9:1978;493-506.
48. 9-tetrahydrocannabinol in mouse spleen cells: a potential mechanism for cannabinoid-mediated immunosuppression. Life Sci. 51:1992;25-30.
49. 9-tetrahydrocannabinol selectively inhibits T-cell dependent humoral immune responses through direct inhibition of accessory T-cell function. Immunopharmacology. 26:1993;129-137.
50. Schatz A.R., Lee M., Condie R., Pulaski J., Kaminski N.E. Cannabinoid receptors CB1 and CB2: a characterization of expression and adenylate cyclase modulation within the immune system. Toxicol. Appl. Pharmacol. 142:1997;278-287.
51. Sevetson B.R., Kong X., Lawrence J.C. Jr. Increasing cAMP attenuates activation of mitogen-activated protein kinase. Proc. Natl. Acad. Sci. USA. 90:1993;10305-10309.
52. Shirakawa F., Mizel S.B. In vitro activation and nuclear translocation of NF-κB catalyzed by cyclic AMP-dependent protein kinase and protein kinase C. Mol. Cell. Biol. 9:1989;2424-2430.
53. Shire D., Carillon C., Kaghad M., Calandra B., Rinaldi-Carmona M., Le Fur G., Caput D., Ferrara P. An amino-terminal variant of the central cannabinoid receptor resulting from alternative splicing. J. Biol. Chem. 270:1995;3726-3731.
54. Siegel M.D., Zhang D.H., Ray P., Ray A. Activation of the interleukin-5 promoter by cAMP in murine EL-4 cells requires the GATA-3 and CLE0 elements. J. Biol. Chem. 270:1995;24548-24555.
55. Sliptz D.H., O'Neill G.P., Favreau L., Dufresne C., Gallant M., Gareau Y., Guay D., Labelle M., Metters K.M. Activation of the human peripheral cannabinoid receptor results in inhibition of adenylyl cyclase. Mol. Pharmacol. 48:1995;352-361.
56. Smith J.W., Steiner A.L., Newberry W.M., Parker C.W. Cyclic adenosine 3′,5′-monophosphate in human lymphocytes: alteration after phytohemagglutinin. J. Clin. Invest. 50:1971;432-441.
57. 9-tetrahydrocannabinol and its relationship to pharmacological potency. J. Pharmacol. Exp. Ther. 255:1990;624-630.
58. Tsuruta L., Lee H., Masuda E., Koyano-Nakagawa N., Arai N., Arai K., Yokota T. Cyclic AMP inhibits expression of the IL-2 gene through the nuclear factor of activated T-cells (NF-AT) site, and transfection of NF-AT cDNAs abrogates the sensitivity of EL-4 cells to cyclic AMP. J. Immunol. 154:1995;5255-5264.
59. Watson P., Krupinski J., Kempinski A., Frankenfield C. Molecular cloning and characterization of the type VII isoform of mammalian adenylyl cyclase expressed widely in mouse tissues and in S49 mouse lymphoma cells. J. Biol. Chem. 269:1994;28893-28898.
60. Wu J., Dent P., Jelinek T., Wolfman A., Weber M.J., Sturgill T.W. Inhibition of the EGF-activated MAP kinase signaling pathway by adenosine 3′,5′-monophosphate. Science. 262:1993;1065-1069.
61. Xie Q., Kashiwabara Y., Nathan C. Role of transcription factor NF-κB/Rel in induction of nitric oxide synthase. J. Biol. Chem. 269:1994;4705-4708.